Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05423470 · ClinicalTrials.gov registry record · NA
Effect of Intermittent Hypoxia on Ischemia-reperfusion Injury in Healthy Individuals
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05423470: Completed NA study, sponsored by University of Texas at Austin.
NCT05423470 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05423470, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The objective of the present study is to determine whether intermittent hypoxia protects against ischemia-reperfusion injury in young and older healthy individuals. The investigators hypothesize that intermittent hypoxia will attenuate the reduction in flow-mediated dilation following ischemia-reperfusion injury.
Primary Outcome
Indicator of nitric oxide-dependent endothelial function
Interventions
- BEHAVIORAL Intermittent hypoxia
- BEHAVIORAL Intermittent normoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-05-30 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
What the finished NCT05423470 record still lists
NCT05423470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Intermittent hypoxia is the first listed.
NCT05423470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05423470 about?
NCT05423470 is a clinical study titled "Effect of Intermittent Hypoxia on Ischemia-reperfusion Injury in Healthy Individuals". The objective of the present study is to determine whether intermittent hypoxia protects against ischemia-reperfusion injury in young and older healthy individuals. The investigators hypothesize that intermittent hypoxia will attenuate the reduction in flow-mediated dilation following ischemia-reper...
What is the current status of trial NCT05423470?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-05-30. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT05423470?
The interventions under investigation include: Intermittent hypoxia (BEHAVIORAL), Intermittent normoxia (BEHAVIORAL).
Who is sponsoring clinical trial NCT05423470?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05423470's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI